If I was a shareholder, I'd be feeling pretty lucky that Pfizer have locked in 14.5c takeover offer.
Thise results are very mediocre, and use case with regard to Covid is dwindling.
Seems like Pfizer got a poor deal, but great for RAP shareholders.
Ann: Results from Data Confirmation Study, page-10
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 416 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)